Estate Counselors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$530K Buy
22,000
+7,000
+47% +$183K 0.05% 76
2026
Q1
$421K Hold
15,000
0.04% 80
2025
Q4
$374K Buy
15,000
+5,000
+50% +$126K 0.03% 81
2025
Q3
$255K Buy
+10,000
New +$247K 0.02% 85
2020
Q4
Sell
-11,984
Closed -$417K 138
2020
Q3
$417K Hold
11,984
0.06% 107
2020
Q2
$371K Buy
+11,984
New +$407K 0.06% 116

Other funds holding PFE

Estate Counselors's PFE Position: Q2 2026 in Review

Estate Counselors increased its Pfizer (PFE) stake by 47% in Q2 2026, buying an estimated $183K and bringing the position to 22,000 shares worth $530K. The position accounts for 0.05% of the portfolio, ranked #76.

Estate Counselors first reported a position in PFE in Q2 2020 and has held it in 6 quarters since. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Estate Counselors held 22,000 shares of Pfizer worth $530K as of Q2 2026.
  • Estate Counselors bought 7,000 Pfizer shares in Q2 2026, an estimated $183K.
  • Pfizer made up 0.05% of Estate Counselors's portfolio in Q2 2026, its #76 holding.
  • Estate Counselors first reported a position in Pfizer in Q2 2020 and has held it in 6 quarters since.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Estate Counselors's 13F filing for Q2 2026, filed 7 Aug 2026.